"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PROSTATE.
| Descriptor ID |
D011471
|
| MeSH Number(s) |
C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
|
| Concept/Terms |
Prostatic Neoplasms- Prostatic Neoplasms
- Prostate Neoplasms
- Neoplasms, Prostate
- Neoplasm, Prostate
- Prostate Neoplasm
- Neoplasms, Prostatic
- Neoplasm, Prostatic
- Prostatic Neoplasm
Prostate Cancer- Prostate Cancer
- Cancer, Prostate
- Cancers, Prostate
- Prostate Cancers
- Cancer of the Prostate
- Prostatic Cancer
- Cancer, Prostatic
- Cancers, Prostatic
- Prostatic Cancers
- Cancer of Prostate
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".
This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 45 | 2 | 47 |
| 1995 | 54 | 2 | 56 |
| 1996 | 49 | 7 | 56 |
| 1997 | 44 | 8 | 52 |
| 1998 | 58 | 7 | 65 |
| 1999 | 73 | 7 | 80 |
| 2000 | 62 | 14 | 76 |
| 2001 | 89 | 5 | 94 |
| 2002 | 88 | 11 | 99 |
| 2003 | 131 | 15 | 146 |
| 2004 | 124 | 14 | 138 |
| 2005 | 136 | 12 | 148 |
| 2006 | 135 | 13 | 148 |
| 2007 | 147 | 8 | 155 |
| 2008 | 132 | 10 | 142 |
| 2009 | 116 | 14 | 130 |
| 2010 | 123 | 21 | 144 |
| 2011 | 162 | 20 | 182 |
| 2012 | 126 | 18 | 144 |
| 2013 | 138 | 13 | 151 |
| 2014 | 107 | 16 | 123 |
| 2015 | 118 | 12 | 130 |
| 2016 | 116 | 16 | 132 |
| 2017 | 104 | 15 | 119 |
| 2018 | 74 | 8 | 82 |
| 2019 | 82 | 4 | 86 |
| 2020 | 98 | 4 | 102 |
| 2021 | 87 | 6 | 93 |
| 2022 | 69 | 1 | 70 |
| 2023 | 66 | 1 | 67 |
| 2024 | 32 | 3 | 35 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.
-
Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells. Nat Commun. 2024 Sep 03; 15(1):7675.
-
RAD21 promotes oncogenesis and lethal progression of prostate cancer. Proc Natl Acad Sci U S A. 2024 Sep 03; 121(36):e2405543121.
-
Cryo-Nanocatalyst Enhances Therapeutic Efficacy of Cryo-Immunotherapy through Necroptosis and Local Delivery of Programmed Death-Ligand 1 Inhibitors. ACS Nano. 2024 Sep 03; 18(35):24269-24282.
-
Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt pathway-induced M2 macrophage polarization. Proc Natl Acad Sci U S A. 2024 Aug 13; 121(33):e2402903121.
-
Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer. Mol Cancer Res. 2024 08 02; 22(8):730-745.
-
Interreader and Intrareader Reproducibility of 18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies. J Nucl Med. 2024 Aug 01; 65(8):1239-1243.
-
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer. Nucleic Acids Res. 2024 Jul 22; 52(13):7740-7760.
-
ProsTAV, a clinically useful test in prostate cancer: an extension study. World J Urol. 2024 Jul 10; 42(1):395.
-
Clinical considerations for sexual and gender minorities with prostate cancer. Urol Oncol. 2024 Nov; 42(11):345-351.
-
True-Positive 18F-Flotufolastat Lesions in Patients with Prostate Cancer Recurrence with Baseline-Negative Conventional Imaging: Results from the Prospective, Phase 3, Multicenter SPOTLIGHT Study. J Nucl Med. 2024 Jul 01; 65(7):1080-1086.